These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 31883400)

  • 41. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J; Dai C; Ding Z; Pan Y; Lu L; Bao J; Zheng J
    BMC Cancer; 2024 Jun; 24(1):759. PubMed ID: 38914958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression.
    Zhao M; Cui H; Zhao B; Li M; Man H
    Int J Mol Med; 2020 Dec; 46(6):2007-2018. PubMed ID: 33125097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factor-2 mRNA-binding protein 3 promotes cell migration, invasion, and epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E-box-binding homeobox 1 mRNA.
    Feng Y; Lin Y; Jiang Z; Wu L; Zhang Y; Wu H; Yuan X
    Mol Carcinog; 2023 Apr; 62(4):503-516. PubMed ID: 36688673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GFI1 promotes the proliferation and migration of esophageal squamous cell carcinoma cells through the inhibition of SOCS1 expression.
    Huang Y; Ruan R; Fang Y; Wu K; Yao L; Zhang R; He W
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.
    Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF
    Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
    Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
    Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
    Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
    Funct Integr Genomics; 2023 May; 23(2):164. PubMed ID: 37198330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
    Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
    Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway.
    Wang Y; Yu XJ; Zhou W; Chu YX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer.
    Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X
    Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpressed COL3A1 has prognostic value in human esophageal squamous cell carcinoma and promotes the aggressiveness of esophageal squamous cell carcinoma by activating the NF-κB pathway.
    Zhou J; Yang Y; Zhang H; Luan S; Xiao X; Li X; Fang P; Shang Q; Chen L; Zeng X; Yuan Y
    Biochem Biophys Res Commun; 2022 Jul; 613():193-200. PubMed ID: 35598375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.